معرفی
Professor Alexander Breeze is a Chair in the School of Medicine at the University of Leeds, affiliated with the Multidisciplinary Cardiovascular Research Centre. His research focuses on structural biology, drug design, and molecular mechanisms of disease, particularly involving protein-protein interactions and NMR spectroscopy. Key areas include RAS oncogene inhibition, fibroblast growth factor receptors (FGFRs), and amyloid aggregation modulation.
Education Background: Details of formal education not explicitly provided in the text, but extensive career history in structural biology and medicinal chemistry suggests advanced degrees in relevant fields.
Research Interests: Professor Breeze’s work spans cardiovascular research, cancer biology, and infectious diseases. He develops novel therapeutics targeting oncogenic signaling pathways (e.g., RAS, FGFR) and investigates mechanisms of protein misfolding in amyloid diseases. His lab employs fragment-based drug design, NMR spectroscopy, and computational methods to study protein dynamics and drug interactions.
Publications Overview: His recent work highlights advancements in small-molecule inhibitors for RAS proteins, CRACR2A genetic associations with COVID-19 severity, and modulation of amyloid aggregation pathways. Research trends emphasize translational applications, bridging basic science and clinical targets like cancer and neurodegenerative diseases.
Awards & Recognition: No specific awards mentioned in the provided text, though his sustained high-impact publications suggest recognition in the field.
Grants & Advising: Leadership in multidisciplinary cardiovascular research and training of early-career researchers through collaborative projects. No explicit grant details provided in this dataset.
Labs & Teams: Active in the Multidisciplinary Cardiovascular Research Centre, fostering cross-departmental collaborations in cardiovascular and structural biology research.
